Excluding Excise Duty and Other Income, represents Net Revenue
Dishman Carbogen Amcis Ltd revenue growth forecast
Expected growth rate Q1, FY2023:
Forecast
Actual
Including amortisation and stock based compensations
Dishman Carbogen Amcis Ltd EPS growth forecast
EPS estimate Q1, FY2023:
Forecast
Actual
Source: S&P Global Market Intelligence
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 13.15 % |
3 Month Return | + 21.41 % |
1 Year Return | + 28.34 % |
Market Stats | |
Previous Close | ₹178.89 |
Open | ₹201.00 |
Volume | 91.12L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹3,332.11Cr |
P/E Ratio | -19.15 |
PEG Ratio | 2.38 |
Market Cap | ₹3,332.11 Cr |
P/B Ratio | 0.91 |
EPS | -9.79 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 0 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹3,332.11 Cr | 15.06% | 0.58 | -₹154 Cr | ₹2,615 Cr | |
NA | ₹4,808.85 Cr | 36.95% | 0.52 | -₹30 Cr | ₹1,369 Cr | |
NA | ₹7.91 Cr | 29.88% | 0.90 | NA | NA | |
NA | ₹4,498.32 Cr | 355.76% | 0.50 | ₹33 Cr | ₹204 Cr | |
NA | ₹0.00 Cr | -12.22% | 0.77 | NA | NA |
Organisation | Dishman Carbogen Amcis Ltd |
Headquarters | Gujarat |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Dishman Carbogen Amcis Ltd
Dishman Carbogen Amcis Limited reported strong Q2 results with sales of INR 7,890.4 million and a net income of INR 330.9 million, reversing last year's loss. However, the six-month results showed a net loss of INR 444.8 million, indicating challenges ahead.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
FII Holding Up
Foreign Institutions have increased holdings from 8.04% to 8.17% in Sep 2024 quarter
Retail Holding Up
Retail Investor have increased holdings from 31.16% to 31.28% in Sep 2024 quarter
Revenue Rich
Revenue is up for the last 2 quarters, 525.21 Cr → 795.69 Cr (in ₹), with an average increase of 34.0% per quarter
Price Rise
In the last 7 days, DCAL stock has moved up by 14.4%
Profit Spike
Netprofit is up for the last 2 quarters, -77.57 Cr → 33.09 Cr (in ₹), with an average increase of 334.4% per quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 62.1% return, outperforming this stock by 33.7%
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 122.5% return, outperforming this stock by 128.1%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 59.32% of holdings in Sep 2024 quarter
MF Holding Down
Mutual Funds have decreased holdings from 1.28% to 1.03% in Sep 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 59.32% | 0.00 | |
Foreign Institutions | 8.17% | 1.61 | |
Mutual Funds | 1.03% | ||
Retail Investors | 31.28% | 0.37 | |
Others | 0.2% | 0.00 |
Dishman Carbogen Amcis Ltd in the last 5 years
Lowest (-599.35x)
March 22, 2023
Today (-19.15x)
November 14, 2024
Industry (54.87x)
November 14, 2024
Highest (338.29x)
July 25, 2022
Dishman Carbogen Amcis Ltd’s net profit jumped 180.9% since last year same period to ₹33.09Cr in the Q2 2024-2025. On a quarterly growth basis, Dishman Carbogen Amcis Ltd has generated 142.66% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2019, Dishman Carbogen Amcis Ltd has declared dividend of ₹0.20 - translating a dividend yield of 0.09%.
Read More about DividendsBearish
Neutral
Bullish
Dishman Carbogen Amcis Ltd is currently in a Bullish trading position according to technical analysis indicators.
Dishman Carbogen Amcis Ltd (DCAL) share price today is ₹212.53
Dishman Carbogen Amcis Ltd is listed on NSE
Dishman Carbogen Amcis Ltd is listed on BSE
PE Ratio of Dishman Carbogen Amcis Ltd is -19.15
PE ratio = Dishman Carbogen Amcis Ltd Market price per share / Dishman Carbogen Amcis Ltd Earnings per share
Today’s traded volume of Dishman Carbogen Amcis Ltd(DCAL) is 91.12L.
Today’s market capitalisation of Dishman Carbogen Amcis Ltd(DCAL) is ₹3332.11Cr.
Dishman Carbogen Amcis Ltd(DCAL | Price |
---|---|
52 Week High | ₹283 |
52 Week Low | ₹133 |
Dishman Carbogen Amcis Ltd(DCAL) share price is ₹212.53. It is down -24.90% from its 52 Week High price of ₹283
Dishman Carbogen Amcis Ltd(DCAL) share price is ₹212.53. It is up 59.80% from its 52 Week Low price of ₹133
Dishman Carbogen Amcis Ltd(DCAL | Returns |
---|---|
1 Day Returns | 33.64% |
1 Month Returns | 13.15% |
3 Month Returns | 21.41% |
1 Year Returns | 28.34% |